---
title: "LPCN: Net loss widened in Q2 2026, but cash position improved and TLANDO royalties increased"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294805024.md"
description: "Q2 2026 saw a net loss increase to $2.6M, with higher R&D and G&A expenses, but cash reserves rose to $23.3M. LPCN 1154's Phase 3 trial missed its primary endpoint, though post hoc analysis excluding an outlier site showed promising results. TLANDO royalty revenue grew year-over-year.Original document: Lipocine Inc. [LPCN] SEC 8-K Current Report — Aug. 4 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-04T10:16:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294805024.md)
  - [en](https://longbridge.com/en/news/294805024.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294805024.md)
generator: "portal-rs"
---

# LPCN: Net loss widened in Q2 2026, but cash position improved and TLANDO royalties increased

Q2 2026 saw a net loss increase to $2.6M, with higher R&D and G&A expenses, but cash reserves rose to $23.3M. LPCN 1154's Phase 3 trial missed its primary endpoint, though post hoc analysis excluding an outlier site showed promising results. TLANDO royalty revenue grew year-over-year.

Original document: Lipocine Inc. \[LPCN\] SEC 8-K Current Report — Aug. 4 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [LPCN.US](https://longbridge.com/en/quote/LPCN.US.md)

## Related News & Research

- [HC Wainwright & Co. reiterates Neutral rating on Lipocine, $4 price target](https://longbridge.com/en/news/299666593.md)
- [Lipocine initiates BLOOM Phase 3 trial of LPCN 1154 oral brexanolone for postpartum depression](https://longbridge.com/en/news/298901484.md)
- [‘Far From Done,’ Says Top Investor About Sandisk Stock](https://longbridge.com/en/news/300141435.md)
- [Banca Popolare di Cortona buys 5% stake in Dometria](https://longbridge.com/en/news/300143901.md)
- [U.S. Investigation into CrowdStrike (CRWD) Ends with No Charges Being Filed](https://longbridge.com/en/news/300158337.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**